The global marine excipient market size is estimated to reach USD 716.3 million in 2023. Due to increasing demand from several industries, sales of marine excipients are predicted to rise with a CAGR of 6.5% during the forecast period. Total valuation is set to reach USD 1,344.9 million by 2033.
| Attributes | Key Insights |
|---|---|
| Estimated Marine Excipient Market Size (2023E) | USD 716.3 million |
| Projected Marine Excipient Market Value (2033F) | USD 1,344.94 million |
| Value-based Marine Excipient Market CAGR (2023 to 2033) | 6.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Marine excipients are derived from maritime sources such as algae, seaweed, and marine animals. They are considered environment-friendly and sustainable, aligning with the increasing consumer preference for eco-conscious products.
Marine excipients are used in several applications due to their distinctive functional characteristics, thereby driving their demand. For instance, seaweed extracts can improve the texture, shelf life, and sensory qualities of food products by thickening, stabilizing, emulsifying, and enhancing flavor.
Growing adoption of marine excipients in the thriving pharmaceutical industry is expected to boost sales. These excipients offer unique functional properties that can enhance the performance of pharmaceutical formulations.
For instance, certain seaweed extracts possess excellent gelling and thickening properties, making them suitable for controlled drug release applications or improving the viscosity and stability of liquid formulations. These properties allow for better drug delivery and enhanced patient experience.
The application of marine excipients in the pharmaceutical industry gives drug scientists more opportunities to experiment with novel formulations and delivery methods. These excipients can be used in several dosage forms, including tablets, capsules, gels, and transdermal patches.
The global marine excipient market witnessed a compound annual growth rate (CAGR) of 6.4% from 2018 to 2022. Over the forecast period, sales of marine excipients are predicted to rise at 6.5% CAGR.
| Historical CAGR (2018 to 2022) | 6.4% |
|---|---|
| Forecast CAGR (2023 to 2033) | 6.5% |
Marine excipients are helpful in a variety of applications due to their functional qualities and adaptability. Using sustainable and natural ingredients in several industries, including pharmaceuticals, has become increasingly popular worldwide. Because they come from marine sources, marine excipients fit this trend and are becoming increasingly popular as natural substitutes.
Pharmaceutical companies and excipient producers have been investing in research and development to investigate the potential of excipients originating from marine sources. This entails looking for fresh marine sources, streamlining the extraction procedure, and comprehending the practical applications of these excipients.
Interest in special excipients has increased due to the creation of novel medication formulations and delivery methods. The potential of marine excipients to provide enhanced bioavailability and controlled release formulations is encouraging their adoption in the pharmaceutical sector. This will boost the target market.
Marine excipients are used in pharmaceutical formulations and drug delivery systems. This broad applicability is likely to fuel global marine excipient demand during the assessment period.
The bioactive substances, vitamins, minerals, and antioxidants found in marine excipients may offer extra health advantages in pharmaceutical applications. These substances help the medication's therapeutic benefits, enhancing patient well-being and minimizing adverse effects.
Principal Consultant
| Attributes | Key Factors |
|---|---|
| Trends |
|
| Growth Hindrances |
|
| Upcoming Opportunities |
|
The table below highlights the anticipated growth rates of different countries. Among these, China and Japan are expected to remain highly lucrative markets for marine excipient companies, exhibiting a CAGR of 7.5% and 6.5% respectively. The United States and India are anticipated to follow with CAGRs of 5.5% and 6.2%, respectively, through 2033.
| Countries | CAGR |
|---|---|
| United States | 5.5% |
| United Kingdom | 4.1% |
| China | 7.4% |
| India | 6.2% |
| Japan | 6.5% |
The United States marine excipient market size is expected to reach USD 287.4 million by 2033. Over the forecast period, demand for marine excipients in the United States is set to rise at a CAGR of 5.5%. This is attributable to rising applications of marine excipients in the United States pharmaceutical industry.
The pharmaceutical industry in the United States is exploring new excipient possibilities to enhance drug delivery mechanisms, increase stability, and optimize formulations. Marine-based excipients offer advantages such as controlled release, solubility, and higher bioavailability for drugs and dietary supplements.
The use of natural and secure ingredients is also encouraged by the United States Food and Drug Administration (FDA) regulatory organization. The increased demand for marine excipients results from both their regulatory backing and their useful qualities.
Marine excipients have unique qualities that can help create better medication delivery systems. To ensure sustained and regulated release of the active pharmaceutical components, some marine excipients, for instance, have gelling or thickening qualities that can aid in drug release management.
China marine excipient market is poised to advance at a CAGR of 7.4% during the assessment period. Total valuation in the country is expected to reach USD 56.7 million in 2023. This is due to easy availability of raw materials and increasing adoption of marine excipients in food & beverage and cosmetics industries.
Due to the vast expanse of shoreline in China, seaweed, algae, and other marine species are abundantly accessible as raw materials for marine products. This natural bounty gives China a competitive edge in sourcing and production through advanced technology utilization.
China’s state-of-the-art manufacturing infrastructure supports the large-scale production of marine excipients. Modern facilities with cutting-edge tools enable effective production, processing, and manufacturing operations. Both domestic and foreign markets benefit from this capacity to fulfill their requirements efficiently.
China has established itself as a leader in producing, consuming, and exporting marine extracts. This is due to its extensive knowledge of marine biotechnology, abundance of marine resources, robust technological advancements, and significant government support.
Japan is expected to hold 2.9% market share of marine excipients globally, reaching a valuation of USD 39.0 million by 2033. Sales of marine excipients in Japan are projected to rise at 6.5% CAGR during the assessment period.
Several factors are expected to drive sales in Japan through 2033. These include advanced aquaculture sector, proficiency in marine biotechnology, robust demand for marine drug formulation ingredients, and rising usage of marine excipients in cosmetics and food sectors.
Japan has a long history of utilizing seaweed, such as nori, wakame, and Kombu, in traditional cuisine and several applications. This rich marine biodiversity contributes to Japan's prominence in the marine excipient market.
Natural and high-quality ingredients are more in demand in Japan's well-established cosmetic and personal care industry. Marine excipients are extremely popular in the Japanese cosmetics industry due to their unique characteristics and potential skin and hair care advantages.
As per the latest analysis, demand for marine excipients in India is anticipated to rise at 6.2% CAGR during the forecast period. It will likely emerge as a highly lucrative market for marine excipient manufacturers across South East Asia.
India's emphasis on sustainability and environmental responsibility is significantly impacting the pharmaceutical sector. Products like marine excipients sourced responsibly are preferred in industries like pharmaceuticals and food & beverages.
There is a growing desire for natural and organic compounds across India. This is expected to elevate demand for marine excipients during the forecast period. The country is also witnessing healthy competition when it comes to cost and performance of marine excipients. Companies that can provide cost-effective and high-quality products will likely succeed in India.
The United Kingdom marine excipient industry is expected to thrive at a CAGR of 4.1% during the forecast period. It will attain a total valuation of USD 126.4 million at the end of 2033. This is attributable to rising demand for sustainable and eco-friendly excipients.
In the United Kingdom, there has been an increase in demand for specialty and natural excipients, particularly those sourced from marine sources. Interest in sustainable and eco-friendly alternatives has grown among consumers and pharmaceutical businesses. This is expected to drive demand in the country.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below section shows the alginate segment dominating the worldwide marine excipient industry. It is forecast to thrive at 5.6% CAGR between 2023 and 2033. Based on source, the sea weed segment is poised to exhibit a CAGR of 8.9% during the forecast period.
| Product Type | Alginate |
|---|---|
| Value CAGR | 5.6% |
As per the latest marine excipient industry analysis, alginate is expected to remain the top-selling product type, thriving at 5.6% CAGR. This is attributable to rising usage of alginate across several industries due to its excellent functional properties.
Alginate is a versatile marine excipient that offers a wide range of functional properties. It is a common choice for several applications, including food, medicine, and cosmetics, due to its propensity to form gels in the presence of calcium ions.
Because of its ability to create various textures and improve product stability, alginate is widely utilized in the food industry. It can be found in culinary goods such as dairy, confectionery, and beverages to increase texture, viscosity, and overall sensory experience.
Alginate is used as an excipient in medication formulations in the pharmaceutical industry. By producing controlled-release matrices or beads, it can be used to control medication release. Because of its biocompatibility and wound-healing characteristics, alginate is also employed in wound dressings and other medical applications.
Alginates are widely applied as rate-controlling excipients in drug delivery systems, as an excipient in pharmaceutical preparations for local application, and as a matrix for biomolecules. Growing adoption in these applications will likely boost the target segment.
| Source | Sea Weed |
|---|---|
| Value CAGR | 8.9% |
As per the latest report, seaweed is expected to remain a key source for deriving marine excipients. The target segment will likely thrive at a robust CAGR of 8.9% during the assessment period.
Seaweed is prevalent along the world's coastlines and proliferates without using freshwater, fertilizers, or pesticides. It is a sustainable and renewable resource for manufacturing marine excipients, which corresponds to the growing need for environmentally beneficial ingredients.
Marine excipients made from seaweed are often used in food sector. Alginate, carrageenan, and agar are widely used in food products to increase texture, stability, and mouthfeel, such as dairy, sweets, sauces, and processed meats.
Seaweed is a sought-after source of marine excipients in food, medicines, cosmetics, and personal care. This is due to its availability, sustainability, functional qualities, and wide range of applications.
The marine excipient industry is highly competitive, with a few key players dominating the business. These players are directing towards innovation, product differentiation, and expanding their distribution channels to gain a competitive advantage.
Recent developments:
| Attribute | Details |
|---|---|
| Estimated Marine Excipient Market Size (2023) | USD 716.3 million |
| Projected Marine Excipient Market Value (2033) | USD 1,344.94 million |
| Anticipated Growth Rate (2023 to 2033) | 6.5% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Volume (MT) and Value (USD million) |
| Key Regions Covered | Europe; North America; South Asia; Latin America; East Asia; Oceania; and Middle East and Africa |
| Key Countries Covered | United States, Brazil, Peru, Argentina, Spain, France, Germany, United Kingdom, Netherlands, Italy, Belgium, Russia, Nordic, Poland, South Korea, China, India, Japan, Malaysia, Mexico, Thailand, Singapore, Canada, Australia, Indonesia, Chile, GCC Countries, Central Africa, New Zealand, South Africa, and others |
| Key Market Segments Covered | Product Type, End Use Industry, Functionality, Source, Form and Regions |
| Key Companies Profile | Blue Biotech; Earthrise; Roquette Kloetze; Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China; AlgaNovo International Co., Ltd, China; Yigeda Bio-Technology Co., Ltd, China; EID Parry; BASF (Cognis Australia, Betatene/BASF (DE); Natural Beta Technologies; Cyanotech; Mera Pharma; BioReal; US Nutra; AlgaTech; Blue Biotech; SandaKing; DIC Lifetec; Marcel Carrageenan; Zamboanga Carrageenan; Multicipta Infodevindo; PT Sumber Alam Lestari; Meck Pharmaceuticals & Chemicals Pvt. Ltd. |
The marine excipient market size is estimated to reach USD 716.3 million in 2023.
Marine excipient demand in India is set to grow at 6.2% through 2033.
The target market size is expected to reach USD 1344.9 million by 2033.
Marine excipients demand is set to grow at 6.5% through 2033.
North America is expected to have a market share of 23.5% by 2033.
Leading manufacturers include FMC Corporation, CP Kelco, and Primex.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Alginate 5.2. Carrageenan 5.3. Agar 5.4. Fucoidan 5.5. Chitosan 5.6. Gelatin 5.7. Marine Polysaccharides 6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use Industry 6.1. Pharmaceutical Industry 6.1.1. Oral Formulations 6.1.2. Tablets 6.1.3. Capsules 6.1.4. Liquid Formulations 6.1.5. Topical Formulations 6.1.6. Others 6.2. Food and Beverage Industry 6.3. Personal Care and Cosmetics Industry 6.4. Agriculture Industry 6.5. Veterinary Industry 6.6. Nutraceutical Industry 6.7. Dietary Supplements 7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Functionality 7.1. Fillers and Diluents 7.2. Suspending and Viscosity Agents 7.3. Binders 7.4. Flavoring Agents 7.5. Disintegrants 7.6. Colorants 7.7. Gelling Agents 7.8. Film Forming Agents 7.9. Coating Agents 8. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 8.1. Algae 8.1.1. Green Algae 8.1.2. Green Microalgae 8.1.3. Blue-Green Algae 8.1.4. Haematococcus Algae 8.2. Cladosiphon 8.3. Seaweed 8.3.1. Brown Seaweed 8.3.2. Red Seaweed 8.4. Crustacean 8.5. Corals 8.6. Freshwater Chlorophyta 8.7. Polysaccharide 9. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form 9.1. Liquid 9.2. Powder 9.3. Granular 9.4. Semi-Solid 10. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. East Asia 10.5. South Asia 10.6. Oceania 10.7. Middle East and Africa 11. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. South Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Oceania Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18. Key Countries Analysis 19. Market Structure Analysis 20. Competition Analysis 20.1. Blue Biotech 20.2. Earthrise 20.3. Roquette Kloetze 20.4. Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China 20.5. AlgaNovo International Co., Ltd, China 20.6. Yigeda Bio-Technology Co., Ltd, China 20.7. EID Parry 20.8. BASF (Cognis Australia, Betatene/BASF (DE)) 20.9. Natural Beta Technologies 20.10. Cyanotech 20.11. Mera Pharma 20.12. BioReal 20.13. USA Nutra 20.14. AlgaTech 20.15. Blue Biotech 20.16. SandaKing 20.17. DIC Lifetec 20.18. Marcel Carrageenan 20.19. Zamboanga Carrageenan 20.20. Multicipta Infodevindo 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Food and Beverage Insights
View Reports
Marine Excipient Market
